PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97530451 |
Filing Date: 08/02/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97530451 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\975\304\97530451\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | zepbound |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) blue and green is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the wording zepbound in stylized font, "zep" in blue and "bound" in green with an imbedded arrow between "p" and "b" and three rounded arrows after the word. |
PIXEL COUNT ACCEPTABLE | NO |
PIXEL COUNT | 4000 x 2250 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Eli Lilly and Company |
*MAILING ADDRESS | Lilly Corporate Center |
*CITY | Indianapolis |
*STATE (Required for U.S. applicants) |
Indiana |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
46285 |
PHONE | 317-651-1346 |
*EMAIL ADDRESS | XXXX |
WEBSITE ADDRESS | www.lilly.com |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Indiana |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
MISCELLANEOUS STATEMENT | The literal element zepbound is a coined, non-dictionary word with no English translation, |
ATTORNEY INFORMATION | |
NAME | Bruce W. Longbottom |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Eli Lilly and Company |
STREET | Lilly Corporate Center |
CITY | Indianapolis |
STATE | Indiana |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 46285 |
PHONE | 317-651-1346 |
FAX | 317 276 1919 |
EMAIL ADDRESS | trademarks@lilly.com |
OTHER APPOINTED ATTORNEY | John R. Rudolph, Gilbert T. Voy, Tonya L. Combs |
CORRESPONDENCE INFORMATION | |
NAME | Bruce W. Longbottom |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@lilly.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | longbottom_bruce@lilly.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /blongbottom/ |
SIGNATORY'S NAME | Bruce W. Longbottom |
SIGNATORY'S POSITION | Associate Vice President-Assistant General Counsel |
SIGNATORY'S PHONE NUMBER | 317-651-1346 |
DATE SIGNED | 08/02/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97530451 |
Filing Date: 08/02/2022 |
The applicant's current Correspondence Information: |
Bruce W. Longbottom |
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@lilly.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): longbottom_bruce@lilly.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|